AbbVie Stock - Weekly chart picture and technical markers under review
18.06.2026 - 16:30:15 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:28 CET. Details in the imprint.
AbbVie (US00287Y1091) is one of the larger US pharmaceutical names on the New York Stock Exchange. With no fresh market-moving headlines today from major newswires or investor relations, the focus shifts to the weekly chart picture and key technical levels.
All news and background on AbbVie stock
Find additional company news, regulatory filings and price data collected around AbbVie stock on our dedicated topic page and via the official investor relations site.
How the weekly chart sets the frame
With no new earnings, guidance or regulatory filings reported on the wires today, AbbVie’s technical picture over the last months becomes the primary lens. Investors often watch the 50-day and 200-day moving averages as orientation for medium-term trends.
On many quote and charting portals, these moving averages are calculated from the daily close on the New York Stock Exchange and updated each trading day. They help to highlight whether the stock currently trades in an established uptrend, in a sideways phase, or near recent support zones.
Key technical levels and volatility
Chart watchers typically mark recent swing highs and lows from the last few weeks as near-term resistance and support areas. These horizontal levels, combined with trend lines and moving averages, can show where buying interest has recently emerged or faded.
Daily range and average true range indicators give a sense of recent volatility. When volatility compresses after a more active period, technicians often speak of a consolidation phase. Wider ranges, by contrast, usually point to a more nervous tape, especially around earnings dates.
The product behind the stock
AbbVie generates its revenue predominantly from prescription medicines in immunology, oncology and neuroscience. Flagship products include the rheumatoid arthritis therapy Humira and newer immunology drugs such as Skyrizi and Rinvoq, alongside treatments in hematologic oncology.
Where the stock trades today
The shares of AbbVie (US00287Y1091) trade on the New York Stock Exchange at $100.00 as of 06/18/2026, 16:28 CET.
AbbVie at a glance
- Company: AbbVie Inc.
- ISIN: US00287Y1091
- WKN: A1J84E
- Ticker: ABBV
- Venue: NYSE
- Price (as of 06/18/2026, 16:28 CET): 100.00 USD
- Market cap: 176,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
